Andrew Hill,
Professor
Professor Andrew Hill gained his BSc(Hons) in Biochemistry and Molecular Biology from Victoria University of Wellington in New Zealand and his PhD at Imperial College, London. He held post-doctoral positions in the MRC Prion Unit (London) and in the Department of Pathology at the University of Melbourne as a Wellcome Trust Prize Travelling Research Fellow. Andrew joined the Department of Biochemistry and Molecular Biology at the University of Melbourne in 2002 and joined the Bio21 Institute when it opened in 2005. In 2015, he moved his laboratory to the La Trobe Institute of Molecular Sciences (LIMS) at La Trobe University where he is also Head of the Department of Biochemistry and Genetics. Andrews research team investigates the mechanisms involved in the spread of misfolded proteins associated with neurodegenerative disorders such as Alzheimer’s, Parkinson’s and prion diseases. His laboratory studies the role that extracellular vesicles such as exosomes play a role in this process. Over the last five years his laboratory has developed an interest in extracellular vesicle RNA and investigated its potential as disease biomarkers for neurological and other conditions. He has been the recipient of several awards and prizes including a Victorian Young Tall Poppy Award in 2006, and the Edman Award (2005) and Merck Research Excellence Medal (2010) from the Australian Society for Biochemistry and Molecular Biology. He has held a number of competitive fellowships including an ARC Future Fellowship (FT3) and NHMRC Senior Research Fellowship. In 2016, Andrew was elected President of the International Society of Extracellular Vesicles (ISEV).
|
|
|
